Issue 32, 2020

PROTAC-mediated degradation of class I histone deacetylase enzymes in corepressor complexes

Abstract

We have identified a proteolysis targeting chimera (PROTAC) of class I HDACs 1, 2 and 3. The most active degrader consists of a benzamide HDAC inhibitor, an alkyl linker, and the von Hippel-Lindau E3 ligand. Our PROTAC increased histone acetylation levels and compromised colon cancer HCT116 cell viability, establishing a degradation strategy as an alternative to class I HDAC inhibition.

Graphical abstract: PROTAC-mediated degradation of class I histone deacetylase enzymes in corepressor complexes

Supplementary files

Article information

Article type
Communication
Submitted
25 Feb 2020
Accepted
11 Mar 2020
First published
11 Mar 2020

Chem. Commun., 2020,56, 4476-4479

PROTAC-mediated degradation of class I histone deacetylase enzymes in corepressor complexes

J. P. Smalley, G. E. Adams, C. J. Millard, Y. Song, J. K. S. Norris, J. W. R. Schwabe, S. M. Cowley and J. T. Hodgkinson, Chem. Commun., 2020, 56, 4476 DOI: 10.1039/D0CC01485K

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements